Cambridge, MA, United States of America

Birgit Schoeberl

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 194(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: The Innovative Contributions of Birgit Schoeberl

Introduction

Birgit Schoeberl, an accomplished inventor based in Cambridge, MA, is making remarkable strides in the field of therapeutic proteins. With 16 patents to her name, her work is paving the way for advancements in tissue repair and regeneration. Her inventive spirit is evident in her focus on bi-specific fusion proteins, which hold significant potential in therapeutic applications.

Latest Patents

Schoeberl's latest innovations include bi-specific fusion proteins designed for therapeutic uses. These proteins are integral to pharmaceutical compositions capable of repairing or regenerating damaged or diseased tissues. The bi-specific fusion proteins generally consist of two key domains: (a) a targeting polypeptide domain that binds to a specific target molecule, and (b) an activator domain that modulates tissue regeneration. Another aspect of her latest patents focuses on fusion proteins that target ischemia-associated molecules, harnessing the power of cellular networks to restore functionality in damaged tissues.

Career Highlights

Throughout her career, Schoeberl has contributed her expertise to notable organizations, including Merrimack Pharmaceuticals, Inc. and Silver Creek Pharmaceuticals, Inc. Her role in these companies has allowed her to advance her research and drive innovations in therapeutic agents that benefit patients. Birgit’s dedication to her work is reflected in her extensive patent portfolio, which underscores her significance in the innovative landscape of biopharmaceuticals.

Collaborations

Schoeberl has collaborated with esteemed professionals in her field, including Ulrik Bjerl Nielsen and Brian Harms. These partnerships have facilitated groundbreaking research and development, enhancing the scope and impact of her innovative endeavors. Teaming up with other experts has allowed her to share insights and refine her inventions, further contributing to advancements in medical science.

Conclusion

Birgit Schoeberl's work exemplifies the nexus of innovation and therapeutic development. Her patents and collaborations reflect a commitment to creating solutions that address critical medical challenges. As her pioneering efforts continue to evolve, the bi-specific fusion proteins she champions may play a crucial role in the future of regenerative medicine, making her an influential figure in the realm of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…